Thrombolytic Science, LLC (TSI), a clinical stage vascular health company developing biotechnology products to treat thrombotic diseases such as myocardial infarction (MI, or heart attack) and stroke
Sartorius, a leading international laboratory and pharmaceutical equipment supplier, yesterday announced a partnership with EMBL, the European Molecular Biology Laboratory.